Scalable Chroman Synthesis Without Pyrophoric Reagents

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for synthesizing 2-methyl-5-((2R,4S)-2-((((R)-1-(naphthalen-1-yl)ethyl)amino)methyl)chroman-4-yl)benzoic acid and its derivatives involve the use of pyrophoric reagents and complex chromatography, making them hazardous and unsuitable for large-scale production, and result in the formation of unwanted impurities.

Innovation Solution

A synthesis process that avoids pyrophoric reagents and chromatography by using mild reducing agents like sodium bis(2-methoxyethoxy)aluminium hydride and ammonium formate, and employs recrystallization techniques to achieve high purity, enabling industrial-scale production with less than 0.2% impurity levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If pyrophoric reagents are used for synthesis, then reaction efficiency is improved, but safety hazards increase and infrastructure costs increase

Engineering Contradiction:
Improvereaction efficiencyVSAvoidsafety hazards
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces pyrophoric reagents with inexpensive, non-pyrophoric reducing agents such as sodium borohydride and aluminum isopropoxide. These reagents are safer, do not require specialized infrastructure, and can be handled under normal laboratory conditions, thereby eliminating safety hazards while maintaining reaction efficiency

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the chemical parameters of the reducing agents from pyrophoric to non-pyrophoric substances. This parameter change allows the reaction to proceed efficiently without the need for specialized safety infrastructure, thus resolving the contradiction between productivity and safety

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If chromatography purification is used, then compound purity is improved, but process complexity and costs increase

Engineering Contradiction:
Improvecompound purityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent extracts and eliminates the chromatography purification step from the synthesis process. Instead, it employs simple filtration and recrystallization techniques that achieve the required purity levels without the complexity and costs associated with chromatography, thus resolving the contradiction between manufacturing precision and device complexity

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces expensive, complex chromatography systems with simple, inexpensive filtration and recrystallization procedures. These simpler methods achieve comparable purity results without requiring sophisticated equipment or extensive operational complexity

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Speed

If harsh hydrogenation conditions are used, then reaction speed is improved, but unwanted impurities increase

Engineering Contradiction:
Improvereaction speedVSAvoidimpurity levels
Core Design Contradiction:
SpeedVSManufacturing precision

Solution Approach 1:

The patent changes the reaction conditions from harsh hydrogenation to milder reducing conditions using reagents like sodium borohydride and aluminum isopropoxide. These milder conditions maintain adequate reaction speed while significantly reducing the formation of unwanted impurities, thereby resolving the contradiction between speed and manufacturing precision

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces mild reducing agents as intermediaries that facilitate the reduction reaction without causing the side reactions and impurity formation associated with harsh hydrogenation conditions. These intermediary reagents enable controlled reaction progression with minimal impurity generation

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process achieves high-purity compounds suitable for industrial-scale production without hazardous reagents, reducing infrastructure costs and impurity levels, while eliminating the need for exogenous hydrogen gas, thus enhancing safety and efficiency.

Implementation Method 1

reducing the amide group of compound-5 using sodium bis(2-methoxyethoxy)aluminium hydride in toluene to give compound-6

Methodology Applied
Scientific EffectReduction: Reduction

Implementation Method 2

reducing compound-1 using Pd/C and ammonium formate to give compound-2

Methodology Applied
Scientific EffectHydrogenation: Hydrogenation

Implementation Method 3

reducing compound-1 using Pd/C and ammonium formate to give compound-2

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 4

employs recrystallization techniques to achieve high purity

Methodology Applied
Scientific EffectCrystallisation: Crystallisation

Data Source

PatentUS12421204B2Process for preparing chroman compounds
Publication Date: 2025.09.23 LUPIN LTD
  • US12421204B2 patent drawing
  • US12421204B2 patent drawing
  • US12421204B2 patent drawing

AI summary

A process for manufacturing substituted chroman compounds in an economically scalable manner, without the use of pyrophoric reagents. Also disclosed herein are chroman compound synthesis routes that do not include column chromatography purification steps. The disclosure also relates to the intermediates used in the synthesis. In particular, the disclosure relates to the synthesis of the Calcium sensing receptor (CaSR) modulating agent 2-methyl-5-((2R,4S)-2-((((R)-1-(naphthalen-1-yl)ethyl)amino)methyl)chroman-4-yl)benzoic acid, its intermediates and pharmaceutically acceptable salts thereof.